Você está na página 1de 2

Biotage Announces Research Collaboration with University of Copenhagen for Pepti

de Synthesis
Biotage, a leading supplier of tools and technology for medicinal and analytical
chemistry, announced an agreement to extend the research collaboration with Pro
fessor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen,
to develop new applications on the Biotage Syro Wave in the field of synthetic
peptide and protein chemistry.
Uppsala, Sweden, May 18, 2010 -- â Biotage (STO: BIOT), a leading supplier of tool
s and technology for medicinal and analytical chemistry, announced an agreement
to extend the research collaboration with Professor Knud J. Jensen at the Facult
y of Life Sciences, University of Copenhagen, to develop new applications on the
Biotage Syro Wave in the field of synthetic peptide and protein chemistry. The
collaboration builds on Professor Jensen's previous research in developing novel
chemistries for and applications of solid-phase peptide synthesis.
Global demand from research scientists for synthetic peptides continues to grow
at a double digit rate. Their needs are for increasingly longer and more complex
peptides to study protein interactions, produce peptide antibodies, and underst
and complex disease states. As the number and complexity of peptides increase, t
he scientists and researchers need new tools that offer higher productivity and
increased performance.
Biotage recently entered into collaboration with the German instrument company M
ultiSynTech GmbH (privately owned by Dr. Udo Treffer) and Professor Jensen to de
velop the Biotage Syro Wave automated peptide synthesizer introduced earlier thi
s year. The instrument combines the proven technologies behind Biotage's Initiat
or microwave instrument with the well-established Syro line of robotic peptide s
ynthesizers from MultiSynTech.
Professor Jensen says The Syro Wave is the first valve-free peptide synthesizer
with integrated microwave heating. It holds great promise for the synthesis of b
oth long peptides and even small proteins.
For more information on the Biotage Syro Wave, please email product_info@biotage
.com or visit www.biotage.com
For further product information contact: Amit Mehrotra, Global Marketing Manager
, Kungsgatan 76, SE-753 18 Uppsala, Sweden. Tel: +46 18 56 59 00 e-mail: Amit.Me
hrotra@biotage.com.
For press information contact: Rob Thompson, Director of Marketing Communication
s, 10430 Harris Oaks Blvd. Suite C, Charlotte, North Carolina, USA Tel: +1 704 6
54 4847 Fax: +1 704 654 4917 e-mail: rob.thompson@biotage.com.
About Biotage:
Biotage offers solutions, knowledge and experience in the areas of analytical an
d medicinal chemistry. The customers include the world's top pharma and biotech
companies, as well as leading academic institutes. The company is headquartered
in Uppsala, Sweden, and has offices in the United States, United Kingdom and Jap
an. Biotage has 253 employees and had sales of SEK 394,1m in 2009. Biotage is li
sted on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com
Press Contact:
Rob Thompson
Director of Marketing Communications
Biotage
10430 Harris Oaks Blvd
Suite C, Charlotte
North Carolina, USA
Tel: +1 704 654 4847
Fax: +1 704 654 4917
rob.thompson@biotage.com
http://www.biotage.com